Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Fertility and Sterility
|
October 1, 1992
Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women
R A Miles, D L Cassidenti, E Carmina, et al.
The Journal of Reproductive Medicine
|
April 1, 1997
Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment
F Z Stanczyk, E Gentzschein, B A Ary, et al.
Fertility and Sterility
|
August 1, 1990
Dehydroepiandrosterone and dehydroepiandrosterone sulfate metabolism in human genital skin
F R Kaufman, F Z Stanczyk, R K Matteri, et al.
Journal of the National Cancer Institute
|
May 17, 2001
Prostate cancer risk and serum levels of insulin and leptin: a population-based study
A W Hsing, S Chua, Y T Gao, et al.
Environmental Health Perspectives
|
April 1, 1997
A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer
G Ursin, S London, F Z Stanczyk, et al.
Journal of the National Cancer Institute
|
June 24, 1999
Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women
G Ursin, S London, F Z Stanczyk, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1987
Production of 3 alpha-androstanediol glucuronide in human genital skin
R A Lobo, W L Paul, E Gentzschein, et al.
Cancer Research
|
April 20, 2001
Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women?
G Ursin, M Wilson, B E Henderson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Fertility and Sterility
|
October 1, 1992
Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women
R A Miles, D L Cassidenti, E Carmina, et al.
The Journal of Reproductive Medicine
|
April 1, 1997
Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment
F Z Stanczyk, E Gentzschein, B A Ary, et al.
Fertility and Sterility
|
August 1, 1990
Dehydroepiandrosterone and dehydroepiandrosterone sulfate metabolism in human genital skin
F R Kaufman, F Z Stanczyk, R K Matteri, et al.
Journal of the National Cancer Institute
|
May 17, 2001
Prostate cancer risk and serum levels of insulin and leptin: a population-based study
A W Hsing, S Chua, Y T Gao, et al.
Environmental Health Perspectives
|
April 1, 1997
A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer
G Ursin, S London, F Z Stanczyk, et al.
Journal of the National Cancer Institute
|
June 24, 1999
Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women
G Ursin, S London, F Z Stanczyk, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1987
Production of 3 alpha-androstanediol glucuronide in human genital skin
R A Lobo, W L Paul, E Gentzschein, et al.
Cancer Research
|
April 20, 2001
Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women?
G Ursin, M Wilson, B E Henderson, et al.
Page
of 2